x

Posted 11 January, 2024

Fuss Brands Corp. appointed new CEO

CEO Change detected for ticker OTC:FBDS in a 8-K filed on 11 January, 2024.


  On January 10, 2024, Issamar Ginzberg tendered his resignation from the Board of Directors of Fuss Brands Corp. (the "Company"). Accordingly, Issamar Ginzberg, serving as the sole director and as the only officer, will cease to be the Company's Chief Executive Officer and Director.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Fuss Brands Corp.
Health Care/Life Sciences • Pharmaceuticals
Fuss Brands Corp. engages in the research, manufacture and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines. Its products include Siberian ginseng, other plant-based anti-depression and nerve regulation products, botanical antibiotics, badger oil, and ginseng and deer antler extracts. The company was founded on August 18, 1988 and is headquartered in New York, NY.
Market Cap
N/A
View Company Details
Fuss Brands Corp. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On January 10, 2024, Issamar Ginzberg tendered his resignation from the Board of Directors of Fuss Brands Corp. (the "Company"). Accordingly, Issamar Ginzberg, serving as the sole director and as the only officer, will cease to be the Company's Chief Executive Officer and Director. There were no disagreements between the Company and Issamar Ginzberg. Also on January 10, 2024, the shareholders of the Company elected Cheskel Meisels to act as the new Chairman of the Board of Directors of the Company. Concurrently with such election, Cheskel Meisels agreed to his appointment.


Mr. Cheskel Meisels, 46, has had a long and notable career in the business industry. Since 2018, he has held the position of CEO at Results Capital LLC. Throughout his career, Meisels has gained recognition for his expertise in advising clients in various sectors such as real estate, health care, insurance, and reinsurance. Over the past decade, Mr. Meisels has been actively involved in debt restructuring, capital reserves, and business development strategies. To date, Mr. Meisels efforts have contributed to the successful restructuring of over one billion dollars of debt, as well as the implementation of effective measures to increase revenues and reduce overhead costs. In June of 2023, Mr. Meisels was appointed CEO of NYS Edge Construction and Concrete LLC.